innoscripta SE
XETRA:1INN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
innoscripta SE
XETRA:1INN
|
DE |
|
Consolidated Edison Inc
NYSE:ED
|
US |
|
S
|
Sinopharm Group Co Ltd
XMUN:X2S
|
CN |
|
D
|
DigitalOcean Holdings Inc
NYSE:DOCN
|
US |
|
Absa Group Ltd
F:AU61
|
ZA |
|
Aya Gold & Silver Inc
TSX:AYA
|
CA |
|
D
|
Danone SA
XHAM:BSN
|
FR |
|
Mercedes-Benz Group AG
XETRA:MBG
|
DE |
|
H
|
Hudbay Minerals Inc
SWB:OCKA
|
CA |
Wall St Price Targets
1INN Price Targets Summary
innoscripta SE
According to Wall Street analysts, the average 1-year price target for 1INN is 216.75 EUR with a low forecast of 202 EUR and a high forecast of 236.25 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1INN's stock price target?
Price Target
216.75
EUR
According to Wall Street analysts, the average 1-year price target for 1INN is 216.75 EUR with a low forecast of 202 EUR and a high forecast of 236.25 EUR.
What is the Revenue forecast for innoscripta SE?
Projected CAGR
39%
The compound annual growth rate for Revenue over the next 4 years is 39%.
What is the Gross Profit forecast for innoscripta SE?
Projected CAGR
38%
The compound annual growth rate for Gross Profit over the next 4 years is 38%.
What is the Operating Income forecast for innoscripta SE?
Projected CAGR
40%
The compound annual growth rate for Operating Income over the next 4 years is 40%.
What is the Pre-Tax Income forecast for innoscripta SE?
Projected CAGR
40%
The compound annual growth rate for Pre-Tax Income over the next 4 years is 40%.
What is the Net Income forecast for innoscripta SE?
Projected CAGR
40%
The compound annual growth rate for Net Income over the next 4 years is 40%.
